Target intelligence / Profile preview

Autophagy Machinery (None)

Target
None
Molecular classification
Protein complex, Kinase signaling pathway, Ubiquitin-like conjugation system, Protease
01

Overview

Autophagy machinery refers to the collection of proteins and complexes that orchestrate autophagy, a conserved cellular process responsible for degrading and recycling cytoplasmic components through lysosome-dependent pathways. This machinery is essential for maintaining cellular homeostasis, responding to stress, and regulating development, immunity, and cell death. The core machinery includes the ULK1 complex (initiation), the PI3K complex (nucleation), ATG9 vesicles and the ATG12-ATG5-ATG16L1 and LC3/GABARAP conjugation systems (elongation), and lysosomal hydrolases (degradation). Autophagy is regulated by nutrient-sensing kinases like mTOR and AMPK. Defects in the pathway are implicated in various diseases, including neurodegeneration and cancer, making it a therapeutic target.

Other names
Autophagy pathwayAutophagosome biogenesisATG proteinsMacroautophagy pathway
02

Mechanism of action

Various, depending on the specific drug and target within the autophagy pathway. mTOR inhibitors activate autophagy by relieving inhibition of the ULK1 complex. Lysosome inhibitors block the degradation of autophagosomal contents. PI3K inhibitors disrupt autophagosome formation.

03

Biological functions

Cellular quality controlResponse to stressNutrient recyclingOrganelle turnoverProtein aggregate degradationPathogen clearanceRegulation of cell survival/death
04

Disease associations

Neurodegenerative disordersCancerInfectionInflammationAging
05

Safety considerations

Context-dependent effects on cancer (tumor suppression vs. promotion)Potential for off-target effects due to the complexity of the pathwayDrug resistanceImmunosuppression
06

Interacting drugs

Rapamycin (mTOR inhibitor)

2 more in the full profile.

07

Biomarkers

LC3-II levelsp62/SQSTM1 levelsAutophagic flux assays

Beyond the preview

Go deeper on Autophagy Machinery (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autophagy Machinery (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call